John F.  Rex net worth and biography

John Rex Biography and Net Worth

John Rex was appointed executive vice president and chief financial officer, UnitedHealth Group, in 2016. In 2012, Rex joined Optum, UnitedHealth Group’s health services business, as executive vice president, chief financial officer. In his prior roles, Rex was a leading equity research analyst, served as a strategy and operational consultant and practiced as a certified public accountant across diverse health care sectors.

What is John F. Rex's net worth?

The estimated net worth of John F. Rex is at least $70.77 million as of July 29th, 2022. Mr. Rex owns 141,508 shares of UnitedHealth Group stock worth more than $70,772,396 as of December 21st. This net worth approximation does not reflect any other assets that Mr. Rex may own. Additionally, Mr. Rex receives an annual salary of $2,670,000.00 as CFO at UnitedHealth Group. Learn More about John F. Rex's net worth.

How old is John F. Rex?

Mr. Rex is currently 62 years old. There are 5 older executives and no younger executives at UnitedHealth Group. The oldest executive at UnitedHealth Group is Mr. James T. Barry Jr., Director of Sales for Western Pennsylvania, who is 78 years old. Learn More on John F. Rex's age.

What is John F. Rex's salary?

As the CFO of UnitedHealth Group Incorporated, Mr. Rex earns $2,670,000.00 per year. The highest earning executive at UnitedHealth Group is Andrew Witty, CEO & Non-Independent Director, who commands a salary of $3,530,000.00 per year. Learn More on John F. Rex's salary.

How do I contact John F. Rex?

The corporate mailing address for Mr. Rex and other UnitedHealth Group executives is 9900 BREN ROAD EAST, MINNETONKA MN, 55343. UnitedHealth Group can also be reached via phone at (952) 936-1300 and via email at [email protected]. Learn More on John F. Rex's contact information.

Has John F. Rex been buying or selling shares of UnitedHealth Group?

John F. Rex has not been actively trading shares of UnitedHealth Group within the last three months. Most recently, John F. Rex sold 13,183 shares of the business's stock in a transaction on Friday, July 29th. The shares were sold at an average price of $541.53, for a transaction totalling $7,138,989.99. Following the completion of the sale, the chief financial officer now directly owns 141,508 shares of the company's stock, valued at $76,630,827.24. Learn More on John F. Rex's trading history.

Who are UnitedHealth Group's active insiders?

UnitedHealth Group's insider roster includes Richard Burke (Director), Paul Garcia (Director), Stephen Hemsley (Director), Patricia Lewis (EVP), Dirk McMahon (Pres & COO ), Dirk McMahon (CEO), Frederick McNabb, III (Director), Erin Mcsweeney (EVP), Steven Nelson (CEO), Larry Renfro (Insider), John Rex (CFO), Thomas Roos (CAO), Marianne Short (EVP), Brian Thompson (Exec. VP & CEO of UnitedHealthcare), David Wichmann (CEO), D. Wilson (EVP), and Andrew Witty (CEO). Learn More on UnitedHealth Group's active insiders.

Are insiders buying or selling shares of UnitedHealth Group?

During the last twelve months, insiders at the healthcare conglomerate sold shares 4 times. They sold a total of 6,445 shares worth more than $3,541,981.98. The most recent insider tranaction occured on July, 18th when EVP Erin Mcsweeney sold 1,500 shares worth more than $868,545.00. Insiders at UnitedHealth Group own 0.3% of the company. Learn More about insider trades at UnitedHealth Group.

Information on this page was last updated on 7/18/2024.

John F. Rex Insider Trading History at UnitedHealth Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/29/2022Sell13,183$541.53$7,138,989.99141,508View SEC Filing Icon  
7/29/2021Sell15,438$412.04$6,361,073.52View SEC Filing Icon  
7/17/2020Sell22,174$308.43$6,839,126.82157,847View SEC Filing Icon  
See Full Table

John F. Rex Buying and Selling Activity at UnitedHealth Group

This chart shows John F Rex's buying and selling at UnitedHealth Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

UnitedHealth Group Company Overview

UnitedHealth Group logo
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Read More

Today's Range

Now: $500.13
Low: $488.73
High: $502.64

50 Day Range

MA: $572.30
Low: $485.52
High: $625.25

2 Week Range

Now: $500.13
Low: $436.38
High: $630.73

Volume

10,923,255 shs

Average Volume

4,115,487 shs

Market Capitalization

$460.26 billion

P/E Ratio

32.58

Dividend Yield

1.73%

Beta

0.58